Garcia, Chad Alior .

HRN: 28-53-08  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/28/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/28/2026
03/07/2026
IVTT
58mg
Q24
UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: